SBIR-STTR Award

Non-invasive Monitoring of Perfusion in Diabetics
Award last edited on: 8/27/08

Sponsored Program
SBIR
Awarding Agency
NIH : NIDDK
Total Award Amount
$372,428
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Gregory T Martin

Company Information

Hemedex Inc (AKA: Thermal Technologies Inc)

222 Third Street Suite 0123
Cambridge, MA 02142
   (617) 577-1759
   info@hemedex.com
   www.hemedex.com
Location: Single
Congr. District: 07
County: Middlesex

Phase I

Contract Number: 1R43DK070408-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2005
Phase I Amount
$168,177
Diabetics with neuropathy are at risk for limb loss due to amputation. Neuropathy and loss of sensation can lead to skin ulcerations that are slow to heal under conditions of low peripheral blood flow. Infection, gangrene and amputation are common occurrences. Early detection of the onset of vascular complications is a critical step in the optimal management of diabetic patients. We plan to develop a system (sensor, monitor and algorithms) that will enable the physician to non-invasively quantify the level of peripheral capillary blood flow in diabetics and anticipate vascular-related complications. The ability to non-invasively monitor peripheral capillary blood flow will: 1) provide an early warning of vascular complications; and 2) help manage therapies that address circulatory problems. The monitoring of peripheral blood flow will help prevent amputations. In the case where an amputation is indicated, quantitative knowledge of peripheral blood flow will help determine the optimal location of the amputation that preserves as much of the limb as possible and insures that the limb flap has adequate blood flow to heal. The goal of this project is the development of a non-invasive clinical device to monitor capillary blood flow. In Phase 1 we will develop a prototype system to quantify peripheral microcirculation using a thermal-based technique (Specific Aims 1 and 2) and we will test this system in the laboratory (Specific Aim 3) and in an animal model (Specific Aim 4). In Phase II, we will develop a beta system and conduct a clinical study to demonstrate the safety and efficacy of the non-invasive perfusion measurement in a diabetic population. The routine clinical use of this device will substantially reduce the need for amputations in diabetics.

Thesaurus Terms:
clinical biomedical equipment, computer assisted diagnosis, diabetes mellitus, diabetic neuropathy, diagnosis design /evaluation, early diagnosis, microcirculation, noninvasive diagnosis, patient monitoring device, thermal blood flow measurement amputation, biological model, capillary, computer program /software, peripheral blood vessel bioengineering /biomedical engineering, swine

Phase II

Contract Number: 5R43DK070408-02
Start Date: 9/30/05    Completed: 8/31/07
Phase II year
2006
Phase II Amount
$204,251
Diabetics with neuropathy are at risk for limb loss due to amputation. Neuropathy and loss of sensation can lead to skin ulcerations that are slow to heal under conditions of low peripheral blood flow. Infection, gangrene and amputation are common occurrences. Early detection of the onset of vascular complications is a critical step in the optimal management of diabetic patients. We plan to develop a system (sensor, monitor and algorithms) that will enable the physician to non-invasively quantify the level of peripheral capillary blood flow in diabetics and anticipate vascular-related complications. The ability to non-invasively monitor peripheral capillary blood flow will: 1) provide an early warning of vascular complications; and 2) help manage therapies that address circulatory problems. The monitoring of peripheral blood flow will help prevent amputations. In the case where an amputation is indicated, quantitative knowledge of peripheral blood flow will help determine the optimal location of the amputation that preserves as much of the limb as possible and insures that the limb flap has adequate blood flow to heal. The goal of this project is the development of a non-invasive clinical device to monitor capillary blood flow. In Phase 1 we will develop a prototype system to quantify peripheral microcirculation using a thermal-based technique (Specific Aims 1 and 2) and we will test this system in the laboratory (Specific Aim 3) and in an animal model (Specific Aim 4). In Phase II, we will develop a beta system and conduct a clinical study to demonstrate the safety and efficacy of the non-invasive perfusion measurement in a diabetic population. The routine clinical use of this device will substantially reduce the need for amputations in diabetics.

Thesaurus Terms:
Clinical Biomedical Equipment, Computer Assisted Diagnosis, Diabetes Mellitus, Diabetic Neuropathy, Diagnosis Design /Evaluation, Early Diagnosis, Microcirculation, Noninvasive Diagnosis, Patient Monitoring Device, Thermal Blood Flow Measurement Amputation, Biological Model, Capillary, Computer Program /Software, Peripheral Blood Vessel Bioengineering /Biomedical Engineering, Swine